federal_register: 2023-02974
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02974 | Inflation Reduction Act (IRA) Initial Program Guidance; Comment Request | Notice | The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' initial guidance for the Medicare Part B and Part D Prescription Drug Inflation Rebate Program for the implementation of the Inflation Reduction Act. CMS will be releasing additional Inflation Reduction Act-related guidance; all can be viewed on the dedicated Inflation Reduction Act section of the CMS website at https://www.cms.gov/inflation-reduction- act-and-medicare/. | 2023-02-13 | 2023 | 2 | https://www.federalregister.gov/documents/2023/02/13/2023-02974/inflation-reduction-act-ira-initial-program-guidance-comment-request | https://www.govinfo.gov/content/pkg/FR-2023-02-13/pdf/2023-02974.pdf | Health and Human Services Department; Centers for Medicare & Medicaid Services | 221,45 | The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' initial guidance for the Medicare Part B and Part D Prescription Drug Inflation Rebate Program for the implementation of the Inflation... |